1. Home
  2. CPIX vs LSTA Comparison

CPIX vs LSTA Comparison

Compare CPIX & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • LSTA
  • Stock Information
  • Founded
  • CPIX 1999
  • LSTA 1980
  • Country
  • CPIX United States
  • LSTA United States
  • Employees
  • CPIX N/A
  • LSTA N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • LSTA Misc Health and Biotechnology Services
  • Sector
  • CPIX Health Care
  • LSTA Health Care
  • Exchange
  • CPIX Nasdaq
  • LSTA Nasdaq
  • Market Cap
  • CPIX 48.5M
  • LSTA 22.3M
  • IPO Year
  • CPIX 2009
  • LSTA N/A
  • Fundamental
  • Price
  • CPIX $3.31
  • LSTA $2.39
  • Analyst Decision
  • CPIX
  • LSTA Strong Buy
  • Analyst Count
  • CPIX 0
  • LSTA 2
  • Target Price
  • CPIX N/A
  • LSTA $23.50
  • AVG Volume (30 Days)
  • CPIX 29.4K
  • LSTA 21.2K
  • Earning Date
  • CPIX 11-06-2025
  • LSTA 11-11-2025
  • Dividend Yield
  • CPIX N/A
  • LSTA N/A
  • EPS Growth
  • CPIX N/A
  • LSTA N/A
  • EPS
  • CPIX N/A
  • LSTA N/A
  • Revenue
  • CPIX $42,071,813.00
  • LSTA $1,070,000.00
  • Revenue This Year
  • CPIX N/A
  • LSTA N/A
  • Revenue Next Year
  • CPIX N/A
  • LSTA N/A
  • P/E Ratio
  • CPIX N/A
  • LSTA N/A
  • Revenue Growth
  • CPIX 11.34
  • LSTA N/A
  • 52 Week Low
  • CPIX $1.04
  • LSTA $1.87
  • 52 Week High
  • CPIX $7.25
  • LSTA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 47.00
  • LSTA 51.61
  • Support Level
  • CPIX $3.21
  • LSTA $2.10
  • Resistance Level
  • CPIX $3.57
  • LSTA $2.43
  • Average True Range (ATR)
  • CPIX 0.20
  • LSTA 0.17
  • MACD
  • CPIX -0.01
  • LSTA 0.02
  • Stochastic Oscillator
  • CPIX 20.83
  • LSTA 82.05

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: